Paxman AB (publ) (STO:PAX)

Market Cap	1.57B
Revenue (ttm)	283.78M
Net Income (ttm)	8.64M
Shares Out	23.27M
EPS (ttm)	0.43
PE Ratio	155.41
Forward PE	33.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,490
Average Volume	138,492
Open	65.20
Previous Close	67.80
Day's Range	65.20 - 68.00
52-Week Range	52.40 - 85.80
Beta	0.29
RSI	41.52
Earnings Date	Nov 14, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 105
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.